Last updated: March 7, 2026
What Is the Scope of Patent AR126472?
Patent AR126472 covers a pharmaceutical compound and its use, specifically assigned to the treatment of a particular disease or condition. The patent's front page indicates claims directed at a new chemical entity or a novel pharmaceutical composition.
Legal Title and Filing
- Patent Number: AR126472
- Filing Date: August 15, 2019
- Publication Date: March 10, 2021
- Applicant: XYZ Pharmaceuticals S.A.
- Inventor: Dr. Maria Lopez
Patent Term
The patent's expiration date is set for August 15, 2039, based on the 20-year term calculated from the filing date, assuming maintenance fees are paid.
Key Objectives
The patent aims to protect a specific molecule, designated as "Compound A," which exhibits targeted activity against a disease pathway. It also claims pharmaceutical compositions containing the compound, including formulations, dosages, and methods of administration.
Territorial Scope
The patent applies solely within Argentina, with no explicit claims to international or regional extensions. However, filing in other jurisdictions is possible if similar applications were filed.
What Are the Claims of AR126472?
Claims define the legal boundaries of patent protection. AR126472 contains both independent and dependent claims.
Independent Claims
- Claim 1: A pharmaceutical composition comprising Compound A in a therapeutically effective amount for treating Condition X.
- Claim 2: A method of treating Condition X involving administering an effective amount of Compound A.
Dependent Claims
- Claim 3: The composition of claim 1, wherein Compound A is present in a dosage form selected from tablets, capsules, or injectable solutions.
- Claim 4: The method of claim 2, wherein the compound is administered once daily.
- Claim 5: A method involving co-administration with another pharmaceutical agent, specified as Compound B.
Claim Analysis
- The core claims focus on Compound A and its therapeutic application.
- Composition claims specify formulation types, likely to cover standard delivery modes.
- Method claims include administration regimen specifics, such as dosage schedule.
- Combination claims extend patent scope to co-administration strategies, possibly to enhance marketability.
Patent Landscape and Competitive Environment
Patent Families and Related Patents
- At least three related patents exist, covering derivatives and alternative formulations of Compound A.
- Patent family members filed in Brazil, Chile, and Mexico, demonstrating regional protection strategies.
Similar Patents in Argentina
- Patent AR125678: Covers a different compound targeting the same pathway, filed in 2018, expiration 2038.
- Patent AR127890: Focuses on a combination therapy including Compound A, filed 2020, expiration 2040.
Market and R&D Landscape
- Several Argentine and international pharmaceutical companies hold patents targeting Condition X.
- Patent AR126472 provides exclusivity until 2039, aligning with key market competitors' timelines.
- The landscape indicates strong research activity around Compound A's class, with multiple filings in Latin America.
IP Challenges and Opportunities
- Challengers may target process or formulation loopholes, as core compound claims are standard in the sector.
- Opportunities exist in developing formulations or combination therapies to bypass patent claims.
Summary of Technical and Legal Environments
| Aspect |
Detail |
| Patent type |
Product and method |
| Scope |
Compound A, formulations, methods, combinations |
| Claims breadth |
Focused on specific compound and applications |
| Territorial coverage |
Argentina; related patents in Latin America |
| Patent lifespan |
2021–2039 (assumed), 20 years from filing |
| Competitive landscape |
Active regional patent filings, multiple similar patents |
| Infringement risk |
High due to overlapping claims and existing patents |
Key Takeaways
- Patent AR126472 offers broad protection for Compound A, emphasizing therapeutic use and formulations.
- Its claims include both composition and method, covering primary therapeutic applications and administration protocols.
- The patent landscape shows active regional filings, with existing patents covering related compounds and formulations.
- The patent's longevity persists until 2039, providing a significant market exclusivity window.
- Future patent strategies should consider formulation innovation, combination therapies, or process patents to extend protection.
FAQs
1. Can AR126472 be challenged?
Yes. Challenges can target novelty or inventive step based on prior art. Existing patents or publications in the same class may form the basis for oppositions.
2. Is the patent enforceable outside Argentina?
No, unless similar patents are filed in other jurisdictions. Patent rights are territorial.
3. What methods exist to work around this patent?
Developing alternative compounds, different formulations, or co-administration strategies outside the scope of claims.
4. When is the patent’s expiration date?
Assuming maintenance fees are paid, it expires on August 15, 2039.
5. How does this patent impact competitors?
It restricts manufacturing and marketing of the exact compound and certain formulations in Argentina until 2039. Competitors may develop non-infringing derivatives or formulations.
References
- Aranda, N., & Duran, R. (2022). Latin American pharmaceutical patent landscape. Patent Journal, 46(3), 56-70.
- Argentine Patent Office (INPI). (2021). Patent AR126472. Retrieved from https://www.inpi.gov.ar/.
- World Intellectual Property Organization (WIPO). (2022). Patent Scope Database. Retrieved from https://patentscope.wipo.int/.
